Form 4 Filing for Angiodynamics Inc.

Stephen A. Trowbridge, EVP and CFO of Angiodynamics Inc., acquired 53,257 shares of common stock through the acquisition of 53,257 restricted stock units on July 15, 2026. These units vest in four equal annual installments starting July 15, 2027. Additionally, Trowbridge acquired 53,257 performance rights, each representing a contingent right to one share of common stock. The number of shares earned will range from 0% to 200% of a target, with a potential adjustment of up to 40% based on total shareholder return over a three-year period, potentially reaching 240% of the target. Shares that do not vest will be forfeited. The acquisition of restricted stock units and performance rights occurred on the same date, with the direct ownership of common stock reported as 297,819 shares post-transaction.